Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are among the most common cancers in humans. Various therapies are currently being used to treat these tumours including surgery, topical treatments and radiotherapy. We describe a new treatment for BCC and SCC. This consists of superficial radiotherapy, using synthetic resin containing a radioactive beta-emitting isotope. The resin is applied to the lesion to perform a selective beta-irradiation brachytherapy treatment.
Sedda, A., Rossi, G., Cipriani, C., Carrozzo, A.m., Donati, P. (2008). Dermatological high-dose-rate brachytherapy for the treatment of basal and squamous cell carcinoma. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 33(6), 745-749 [10.1111/j.1365-2230.2008.02852.x].
Dermatological high-dose-rate brachytherapy for the treatment of basal and squamous cell carcinoma
CARROZZO, ANNA MARIA;
2008-11-01
Abstract
Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are among the most common cancers in humans. Various therapies are currently being used to treat these tumours including surgery, topical treatments and radiotherapy. We describe a new treatment for BCC and SCC. This consists of superficial radiotherapy, using synthetic resin containing a radioactive beta-emitting isotope. The resin is applied to the lesion to perform a selective beta-irradiation brachytherapy treatment.| File | Dimensione | Formato | |
|---|---|---|---|
|
Dermatological high-dose-rate brachytherapy.pdf
accesso aperto
Licenza:
Creative commons
Dimensione
340.29 kB
Formato
Adobe PDF
|
340.29 kB | Adobe PDF | Visualizza/Apri |
Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons
